beta-lapachone has been researched along with Leishmaniasis, American in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreno, E | 1 |
| Schwartz, J | 1 |
| Larrea, E | 1 |
| Conde, I | 1 |
| Font, M | 1 |
| Sanmartín, C | 1 |
| Irache, JM | 1 |
| Espuelas, S | 1 |
1 other study available for beta-lapachone and Leishmaniasis, American
| Article | Year |
|---|---|
Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
Topics: Administration, Topical; Animals; Antiparasitic Agents; Chitosan; Drug Carriers; Drug Delivery Syste | 2015 |